Aspirin Use and Lung Cancer in Men
Author Information
Author(s): Holick C N, Michaud D S, Leitzmann M F, Willett W C, Giovannucci E
Primary Institution: Harvard School of Public Health
Hypothesis
Does regular use of aspirin reduce lung cancer incidence in men?
Conclusion
The study found no significant association between regular aspirin use and lung cancer risk among male health professionals.
Supporting Evidence
- The study included a large cohort of male health professionals with detailed smoking histories.
- Regular aspirin use was defined as taking it two or more times per week.
- Follow-up for cancer incidence was conducted biennially with a high response rate.
Takeaway
The study looked at whether taking aspirin regularly helps prevent lung cancer in men, but it found that it doesn't seem to make a difference.
Methodology
The study used data from the Health Professionals Follow-Up Study, analyzing aspirin use and lung cancer incidence over time.
Potential Biases
There may be risks of bias due to the reliance on self-reported data for aspirin use.
Limitations
The study faced limitations such as potential misclassification of aspirin use and residual confounding from smoking habits.
Participant Demographics
The study involved 51,529 US male health professionals aged 40-75 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website